ArticlePloS one2011

'Multi-epitope-targeted' immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptides.

Nathali Kaushansky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.